ArticleAdvances in therapy2022

Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials.

Andrew M Blumenfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.